1. Allender, S., Scarborough, P., Peto, V., Rayner, M., Leal, J., Luengo-Fernandez, R., Gray, A.: European cardiovascular disease statistics. Brussels: European Heart Network (2008)
2. Roger, V.L., Go, A.S., Lloyd-Jones, D.M., Adams, R.J., Berry, J.D., Brown, T.M., Carnethon, M.R., Dai, S., de Simone, G., Ford, E.S., et al.: Heart disease and stroke statistics–2011 update: A report from the american heart association. Circulation 123(4), e18–e209 (2011)
3. Rangayyan, R.M.: Biomedical Signal Analysis: A Case-Study Approach. IEEE Press (2002)
4. Luthra, A.: ECG made easy. Jaypee Brothers Medical Pub. (2012)
5. U.S. Department of Health and Human Services - Food and Drug Administration and Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER). Guidance for industry: E14 clinical evaluation of qt/qtc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. Regulatory Information (October 2005)